Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


REGENXBIO Announces Dosing Of First Patient In Phase II ALTITUDE Trial Of RGX-314


RTTNews | Dec 10, 2020 07:21AM EST

07:20 Thursday, December 10, 2020 (RTTNews) - REGENXBIO Announces Dosing Of First Patient In Phase II ALTITUDE Trial Of RGX-314

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC